Hikmat Al-Ahmadie

43PUBLICATIONS
352CO-AUTHORS
Cancer diagnosisSolid tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Neural engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Aug 05, 2026
Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group.

|Jul 23, 2026
Induction and characterization of neoplastic bladder tumors in a transgenic porcine model.

|Jun 26, 2026
Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models.

|Feb 09, 2026
Urinary Biomarkers Objectively Measure Minimal Residual Disease in Non-Muscle-Invasive Bladder Cancer.

Andrew B Katims, Charlie White, Syed Muneeb Alam

|Feb 02, 2026
Neoadjuvant Nivolumab with or without Ipilimumab for Cisplatin-Ineligible Patients with Muscle-Invasive Bladder Cancer.

Brendan J Guercio, Eugene J Pietzak, Vignesh Ravichandran

|Dec 20, 2025
Determinants of sensitivity to HER2-targeted antibody drug conjugates in urothelial cancer.

Ziyu Chen, Xinran Tang, Jordan E Eichholz

Pageof 8

Frequent Collaborators

17 joint publications

David Solit

16 joint publications

Gopakumar V Iyer

14 joint publications

Samuel Funt

12 joint publications

Min Yuen Teo